$170.12
-0.0900 (-0.0529%)
At Close: Aug 04, 2026
3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March
05:35am, Monday, 11'th Mar 2024
Johnson & Johnson's stellar fundamentals make it a no-brainer. Becton, Dickinson is an underrated compounder with decades of excellence.
BD (BDX) Initiates IDE Study to Aid Treatment of Artery Disease
09:31am, Tuesday, 05'th Mar 2024
BD (BDX) commences the enrollment of the first patient in the IDE study for the assessment of the company's Vascular Covered Stent for the treatment of Peripheral Arterial Disease.
3 Stocks to Buy at 52-Week Lows: March 4 Edition
05:35pm, Monday, 04'th Mar 2024
Dumpster diving can be fun! One man's trash is another's treasure, particularly when investing.
Becton, Dickinson And Company: Growth Starts To Normalize (Rating Upgrade)
05:16am, Monday, 04'th Mar 2024
Becton, Dickinson and Company (BD) experienced weak growth in China, with a decline of 5.3% year-over-year. BD's major challenges, including the Alaris pump and Covid comparisons, are starting to norm
Get Paid While You Wait: 7 Dividend Aristocrats to Buy Now
01:28pm, Tuesday, 27'th Feb 2024
The stock market bulls are charging right now. The Federal Reserve appears set to lower interest rates this year, which could stoke equity markets.
BD (BDX), Camtech Health Unite to Aid Cervical Cancer Screening
12:16pm, Friday, 23'rd Feb 2024
BD (BDX) collaborates with Camtech Health to improve the rate of cervical cancer screening in Singapore by offering women an option to self-collect samples in the privacy of their own homes.
BDX or WST: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 13'th Feb 2024
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or West Pharmaceutical Services (WST). But which of these two stocks is more a
BD to Present Next Installment of BD Innovates Series: Spotlight on Peripheral Vascular Disease
04:43pm, Monday, 12'th Feb 2024
FRANKLIN LAKES, N.J. , Feb. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installm
Three Reasons to Retain BD (BDX) Stock in Your Portfolio
11:31am, Tuesday, 06'th Feb 2024
BD's (BDX) slew of product launches raises optimism about the stock.
Becton, Dickinson and Company (BDX) Q1 2024 Earnings Call Transcript
11:41am, Thursday, 01'st Feb 2024
Becton, Dickinson and Company (BDX) Q1 2024 Earnings Call Transcript
Becton, Dickinson and Company (BDX) Q1 2024 Earnings Call Transcript
11:41am, Thursday, 01'st Feb 2024
Becton, Dickinson and Company (BDX) Q1 2024 Earnings Call Transcript
BD (BDX) Q1 Earnings Surpass Estimates, Margins Contract
11:36am, Thursday, 01'st Feb 2024
BD's (BDX) overall top line benefits from revenue growth in the majority of its segments and both geographic regions in the fiscal first quarter.
Becton Dickinson (BDX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
10:37am, Thursday, 01'st Feb 2024
While the top- and bottom-line numbers for Becton Dickinson (BDX) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metric
Becton Dickinson (BDX) Q1 Earnings Surpass Estimates
08:41am, Thursday, 01'st Feb 2024
Becton Dickinson (BDX) came out with quarterly earnings of $2.68 per share, beating the Zacks Consensus Estimate of $2.39 per share. This compares to earnings of $2.98 per share a year ago.
Becton Dickinson lifts 2024 profit forecast on surgical devices strength
07:23am, Thursday, 01'st Feb 2024
Becton Dickinson beat first-quarter profit estimates and raised its full-year earnings forecast on Thursday as it benefits from strong demand for its surgical equipment.
Sign In
Buy BDX